October 8, 2024
TOPLINE: Durvalumab therapy after chemoradiotherapy significantly improves overall and progression-free survival in patients with limited-stage small cell lung cancer (SCLC). The median overall survival was 55.9 […]
October 8, 2024
TOPLINE: Coordinated care in a combined rheumatology and ophthalmology clinic for managing pediatric anterior uveitis resulted in better outcomes, quicker initiation of biologic disease-modifying antirheumatic drugs […]
October 8, 2024
TOPLINE: Gestational supplementation of 1000 IU/d cholecalciferol (vitamin D3) from early pregnancy until delivery increases the bone mineral content, bone mineral density (BMD), and bone mineral […]
October 7, 2024
TOPLINE: Stereotactic body radiotherapy (SBRT) and hypofractionated conventional radiotherapy led to similar tumor control and survival outcomes at 3 years in patients with peripheral and central […]
October 7, 2024
TOPLINE: A higher rate of weight loss within 1 year of initiating orlistat is associated with lower risks for incident gout and recurrent gout flares in […]
October 7, 2024
TOPLINE: Older adults with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis face a higher risk for end-stage renal disease or mortality and severe infections. However, frailty, more than […]
October 7, 2024
TOPLINE: Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and […]
October 7, 2024
TOPLINE: Eczematous dermatitis, folliculitis, and seborrheic dermatitis were the most common skin conditions in patients with Down syndrome (DS) in a 10-year retrospective review. METHODOLOGY: Researchers […]
October 4, 2024
TOPLINE: Patients with inflammatory rheumatic diseases who are systematically screened for common chronic and preventable diseases are more likely to receive preventive medications and less likely […]